Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
Prostacyclin therapy is a mainstay of the management of pulmonary arterial hypertension (PAH). Inhaled prostacyclins present safe and effective options for the management of PAH that limit systemic side effects. We describe the first reported case of life-threatening bronchospasm and acute respiratory failure associated with inhaled prostacyclin administration.
Authors
- Brian Murray (ORCID: https://orcid.org/0000-0001-6660-9749)
- Donna Steinbacher
- Shannon S. Carson (ORCID: https://orcid.org/0000-0001-6220-7005)
- H. James Ford (ORCID: https://orcid.org/0009-0003-2057-3914)
- Thomas Devlin (ORCID: https://orcid.org/0000-0003-2156-8327)
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2024-09-04
- DOI
- https://doi.org/10.17615/40r4-by12
- Primary Topic
- Respiratory and Cough-Related Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00